Korean J Ophthalmol.  2019 Oct;33(5):475-477. 10.3341/kjo.2018.0121.

Atypical Fundus Manifestation of Ocular Toxocariasis

• Kim J
• Chin HS

• KMID: 2459530
• DOI: http://doi.org/10.3341/kjo.2018.0121

Abstract

No abstract available.

MeSH Terms

Toxocariasis*

Figure

• 

  Fig. 1 Initial and follow-up fundus photography. (A–F) Case 1. (A) Initial visit on February 22, 2012; follow-up visits on (B) May 30, 2012, (C) June 8, 2012, (D) June 22, 2012, (E) June 29, 2012, and (F) September 5, 2012. (G–O) Case 2. Initial visit on (G) December 12, 2016; follow-up visits on (H) December 19, 2016, (I) December 23, 2016, (J) December 30, 2016, (K) January 5, 2017, and (L) January 19, 2017; (M) enlarged image on December 12, 2016; (N) enlarged image on December 23, 2016; (O) enlarged image on January 19, 2017.

Reference

1. Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev. 2003; 16:265–272. PMID: 12692098.

2. Ahn SJ, Woo SJ, Jin Y, et al. Clinical features and course of ocular toxocariasis in adults. PLoS Negl Trop Dis. 2014; 8:e2938. PMID: 24922534.

3. Bae KW, Ahn SJ, Park KH, Woo SJ. Diagnostic value of the serum anti-Toxocara IgG tilter for ocular toxocariasis in patients with uveitis at a tertiary hospital in Korea. Korean J Ophthalmol. 2016; 30:258–264. PMID: 27478352.

4. Woodhall D, Starr MC, Montgomery SP, et al. Ocular toxocariasis: epidemiologic, anatomic, and therapeutic variations based on a survey of ophthalmic subspecialists. Ophthalmology. 2012; 119:1211–1217. PMID: 22336630.

5. Ahn SJ, Ryoo NK, Woo SJ. Ocular toxocariasis: clinical features, diagnosis, treatment, and prevention. Asia Pac Allergy. 2014; 4:134–141. PMID: 25097848.